Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group.

Beck, T M

Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group. [electronic resource] - Cancer investigation 1997 - 297-303 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0735-7907

10.3109/07357909709039729 doi


Administration, Oral
Adult
Aged
Aged, 80 and over
Antiemetics--adverse effects
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Appetite--drug effects
Cyclophosphamide--administration & dosage
Double-Blind Method
Doxorubicin--administration & dosage
Drug Administration Schedule
Female
Humans
Male
Methotrexate--administration & dosage
Middle Aged
Nausea--chemically induced
Neoplasms--drug therapy
Ondansetron--adverse effects
Time Factors
Vomiting--chemically induced